These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2328452)

  • 1. Effect of furegrelate on renal plasma flow after angiotensin II infusion.
    Kaushal RD; Wilson TW
    Can J Physiol Pharmacol; 1990 Apr; 68(4):500-4. PubMed ID: 2328452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane synthase inhibition enhances furosemide-induced renal vasodilation.
    Wilson TW; Badahman AH; Kaushal RD
    Clin Invest Med; 1993 Oct; 16(5):372-8. PubMed ID: 8261690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A renal vasodilator effect of angiotensin II revealed by dual thromboxane inhibition.
    Badahman AH; Wilson TW
    Can J Physiol Pharmacol; 1994 Jun; 72(6):632-6. PubMed ID: 7954094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diltiazem increases renal prostacyclin.
    Wilson TW; Sharif MN; Kaushal RD
    Clin Invest Med; 1991 Dec; 14(6):596-9. PubMed ID: 1794211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane mediates renal hemodynamic response to infused angiotensin II.
    Wilcox CS; Welch WJ; Snellen H
    Kidney Int; 1991 Dec; 40(6):1090-7. PubMed ID: 1837063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans.
    Weir MR; Klassen DK; Shen SY; Sullivan D; Buddemeyer EU; Handwerger BS
    Transplantation; 1990 Jan; 49(1):41-7. PubMed ID: 2301025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased renal vascular sensitivity to angiotensin II in hypertension is due to decreased response to prostaglandins.
    Palmgren E; Widgren B; Aurell M; Herlitz H
    J Hypertens; 2003 May; 21(5):969-76. PubMed ID: 12714872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the "redirection hypothesis" of prostaglandin metabolism in the kidney.
    Datar S; McCauley FA; Wilson TW
    Prostaglandins; 1987 Feb; 33(2):275-85. PubMed ID: 3296006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins and the renal responses to haemorrhage, angiotensin II and methoxamine in conscious rabbits.
    Bartley PJ; Anderson WP
    Clin Exp Pharmacol Physiol; 1984; 11(1):71-80. PubMed ID: 6424989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclooxygenase and thromboxane synthetase inhibition on furosemide-stimulated plasma renin activity.
    Datar S; McCauley FA; Wilson TW
    Can J Physiol Pharmacol; 1987 Jan; 65(1):80-3. PubMed ID: 3105853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diltiazem potentiates angiotensin II-mediated renal prostacyclin synthesis.
    Sharif MN; Kaushal RD; Iyer P; Wilson TW
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):638-42. PubMed ID: 1280721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II influences the renal hemodynamic response to blockade of thromboxane A2 and prostaglandin H2 receptors.
    Yamaguchi Y; Fenoy FJ; Roman RJ; Nasjletti A
    J Pharmacol Exp Ther; 1992 Dec; 263(3):905-9. PubMed ID: 1469647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of brain thromboxane A in hypotension induced by haemorrhage in rats.
    Yalcin M; Cavun S; Yilmaz MS; Cengiz F; Savci V
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):960-7. PubMed ID: 16405453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane mediation of the pressor response to infused angiotensin II.
    Wilcox CS; Welch WJ
    Am J Hypertens; 1990 Mar; 3(3):242-9. PubMed ID: 2322437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of medullary plasma flow in the attenuated furosemide response in indomethacin-treated rats.
    Kirchner KA
    J Pharmacol Exp Ther; 1989 Jun; 249(3):757-61. PubMed ID: 2732945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclooxygenase and thromboxane synthase inhibition on the response to angiotensin II in the hypoperfused canine kidney.
    Goto F; Jackson EK; Ohnishi A; Herzer W; Branch RA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):799-803. PubMed ID: 3121844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats.
    Chatziantoniou C; Daniels FH; Arendshorst WJ
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F372-82. PubMed ID: 2386211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of thromboxane synthesis has no influence on HgCl2-induced acute renal failure in the rat.
    Vanholder R; Laekeman G; Herman A; Saragananda B; Waterloos MA; Kesteloot D; Lámeire N
    Nephrol Dial Transplant; 1989; 4(7):625-31. PubMed ID: 2510059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of noradrenergic neurotransmission by the thromboxane synthetase inhibitor, UK 38,485.
    Jackson EK; Uderman HD; Herzer WA; Branch RA
    Life Sci; 1984 Jul; 35(2):221-8. PubMed ID: 6330486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.